ARID1A deficiency associated with MMR deficiency and a high abundance of tumor-infiltrating lymphocytes predicts a good prognosis of endometrial carcinoma.

Sun, Dantong; Zhao, Han; Zhou, Hai; Tao, Junyan; Li, Tianjun; Zhu, Jingjuan; Hou, Helei

Sun, Dantong; Zhao, Han; Zhou, Hai; Tao, Junyan; Li, Tianjun; Zhu, Jingjuan; Hou, Helei.

Afiliação

Sun D; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Zhao H; Department of Pathology, The Affiliated Hospital of Qingdao University, 266000, Qingdao, China.
Zhou H; Precision Medicine Center of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Tao J; Precision Medicine Center of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Li T; Precision Medicine Center of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Zhu J; Precision Medicine Center of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Hou H; Precision Medicine Center of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China. Electronic address: houhelei@qdu.edu.cn.

Transl Oncol ; 33: 101685, 2023 Jul.

Article em En | MEDLINE | ID: mdl-37137217

Palavras-chave

ARID1A; Endometrial carcinoma; Mismatch repair; Prognosis; Tumor microenvironment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Transl Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google